Icon
+91 94997 68112
Login Register

Vivelle Dot - (0.025,0.0375,0.05,0.075,0.1mg/24hr; Transdermal System)

Estradiol Novartis
0.025,0.0375,0.05,0.075,0.1mg/24hr; Transdermal System
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated in Treatment of moderate to severe vasomotor symptoms associated with the menopause
Yes
***** *** *** ***** ** **** **** ** **** ******* *******- *** **, **** ; *******- *** *, **** *** *** ************ *********. **** ******* **** *** ** ****** ****** ********** ******* * ********** **** ***** ********* ** ***** ***** *** ****** *** ******* ** *** **, **** ** ******* ***** ******* *************.
  1. *** **, **** : ***** ******** ***** & ******** ***** *** **** ** **** ******* *******- *** **, **** ; *******- *** *, ****.
  2. *** **, **** : ********** ***** * **** ******* ***** ** ******** ***** ** ******** ******** ** *******.
  3. *** **, **** : ********** ******* * ********** **** ***** ********* ** ***** ***** *** ****** *** ******* ** *** **, ****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.